Federal panel urging Canada to ramp up efforts to collect blood plasma
OTTAWA — Canada needs to do more to collect and stockpile its own homegrown plasma, the blood component used to make various medical treatments including life-saving drugs known as immune globulins, a federal panel of experts recommended Wednesday.
In its newly released final report, the panel appointed last year by Health Canada was careful to point out it has found no evidence of a looming crisis in the supply of immune globulins, which help the body fight infections, or other products derived from blood plasma.
Nor can it point to any evidence that plasma derived from paid donors is unsafe, the report notes.
Canada — the second-highest per-capita user of immune globulins in the world — is dangerously dependent on paid donors in the U.S., which provide some 83 per cent of the plasma used north of the border, it says. Domestic donations comprise just 17 per cent.


